Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A variable risk clinical prognostic compartmental model.

P R Sheehe

    Journal of Theoretical Biology
    |December 7, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Odorant confusion matrix: the influence of patient history on patterns of odorant identification and misidentification in hyposmia.

    Physiology & behavior·2001
    Same author

    Odorant quality perception: a metric individual differences approach.

    Perception & psychophysics·2000
    Same author

    A comparative fMRI study of cortical representations for thermal painful, vibrotactile, and motor performance tasks.

    NeuroImage·1999
    Same author

    Odorant threshold following methyl bromide-induced lesions of the olfactory epithelium.

    Physiology & behavior·1998
    Same author

    Odorant-specific spatial patterns in mucosal activity predict perceptual differences among odorants.

    Journal of neurophysiology·1995
    Same author

    Olfactory performance during childhood. II. Developing a discrimination task for children.

    The Journal of pediatrics·1995
    Same journal

    Evolution of quantitative traits: exploring the ecological, social and genetic bases of adaptive polymorphism.

    Journal of theoretical biology·2026
    Same journal

    The male-biased sex ratio in humans and its role in the transition from promiscuity to pair bonding.

    Journal of theoretical biology·2026
    Same journal

    Quantifying the counter-intuitive effects of vaccination by coupling the transmission dynamics of COVID-19 and the evolution of human behaviors.

    Journal of theoretical biology·2026
    Same journal

    An integrative model of FGF2-induced signaling and muscle cell proliferation.

    Journal of theoretical biology·2026
    Same journal

    A hybrid reaction-diffusion and mechanical stimulus model for mandibular bone remodeling under chewing and vibratory loading.

    Journal of theoretical biology·2026
    Same journal

    Integrated tick management strategies in fragmented peridomestic environments.

    Journal of theoretical biology·2026
    See all related articles

    This study introduces a predictive model for disease endpoints using baseline variables and intermediate events. The model employs maximum likelihood estimation and stepwise procedures for risk function analysis.

    Area of Science:

    • Biostatistics
    • Epidemiology
    • Predictive Modeling

    Background:

    • Accurate prediction of disease endpoints is crucial for public health.
    • Understanding the impact of baseline variables and intermediate events aids in risk assessment.

    Purpose of the Study:

    • To describe and illustrate a novel model for predicting disease endpoints.
    • To develop and apply maximum likelihood equations for risk function analysis.

    Main Methods:

    • Development of maximum likelihood equations.
    • Application of stepwise upward procedures for variable selection.
    • Estimation of coefficients in risk functions using a small dataset.

    Main Results:

    • The described model effectively predicts disease endpoints.

    Related Experiment Videos

  • Numerical examples demonstrate the model's application.
  • Maximum likelihood estimates provide insights into variable contributions.
  • Conclusions:

    • The proposed model offers a robust framework for disease endpoint prediction.
    • The methodology is applicable to various epidemiological and clinical datasets.
    • Further validation on larger datasets is warranted.